Literature DB >> 29577313

The Impact of the Roast Levels of Coffee Extracts on their Potential Anticancer Activities.

Benigno E Mojica1, Lisa E Fong1, Denny Biju1, Alfeah Muharram1, Isabel M Davis1, Klarisse O Vela1, Diana Rios1, Elena Osorio-Camacena1, Baljit Kaur1, Sebastian M Rojas1, Sarah C Forester1.   

Abstract

Coffee is one of the most widely consumed beverages in the world and contains numerous phytochemicals that are beneficial to consumer health. The phytochemical profile of coffee, however, can be affected by the roast level. In this study, we compared the effect of roasting level on the growth inhibitory activity of HT-29 (colon) and SCC-25 (oral) cancer cell lines. The different roasting stages selected for this study were green, cinnamon/blonde, city/medium, full city/medium-dark, and full city plus/dark. Cancer cells were treated with various concentrations of coffee extracts for 72 hr. Cell viability was quantified using the thiazolyl blue tetrazolium bromide assay. It was found that the lighter roast extracts, Cinnamon in particular, reduced cell growth more than darker roast extracts. The Cinnamon extract had the greatest amount of total phenolic content and antioxidant activity. Relative levels of gallic, caffeic, and chlorogenic acid in the extracts were also compared. The Cinnamon coffee extract had the highest levels of gallic and caffeic acids, which have both been widely-regarded as bioactive phytochemicals. In conclusion, the consumption of lighter roasted coffee, may contribute to the prevention of certain types of cancer such as oral and colon. PRACTICAL APPLICATION: Chemical compounds in coffee may reduce the risk for certain types of cancers. These compounds may be particularly abundant in lighter roasted coffee. Therefore, lighter roasted coffee could contribute to the prevention of cancer through a healthy diet.
© 2018 Institute of Food Technologists®.

Entities:  

Keywords:  cancer; coffee; phenolic compounds; roasting

Mesh:

Substances:

Year:  2018        PMID: 29577313     DOI: 10.1111/1750-3841.14102

Source DB:  PubMed          Journal:  J Food Sci        ISSN: 0022-1147            Impact factor:   3.167


  7 in total

1.  Coffee Bean Polyphenols Can Form Biocompatible Template-free Antioxidant Nanoparticles with Various Sizes and Distinct Colors.

Authors:  Suhair Sunoqrot; Eveen Al-Shalabi; Amal G Al-Bakri; Hiba Zalloum; Bashaer Abu-Irmaileh; Lina Hasan Ibrahim; Huda Zeno
Journal:  ACS Omega       Date:  2021-01-18

2.  Applying Box-Behnken Design for Formulation and Optimization of PLGA-Coffee Nanoparticles and Detecting Enhanced Antioxidant and Anticancer Activities.

Authors:  Nouran S Sharaf; Amro Shetta; Jailan E Elhalawani; Wael Mamdouh
Journal:  Polymers (Basel)       Date:  2021-12-31       Impact factor: 4.329

3.  Association between Coffee Consumption/Physical Exercise and Gastric, Hepatic, Colon, Breast, Uterine Cervix, Lung, Thyroid, Prostate, and Bladder Cancer.

Authors:  So Young Kim; Dae Myoung Yoo; Chanyang Min; Hyo Geun Choi
Journal:  Nutrients       Date:  2021-11-02       Impact factor: 5.717

4.  Antitumor Effects of Freeze-Dried Robusta Coffee (Coffea canephora) Extracts on Breast Cancer Cell Lines.

Authors:  Ayelén D Nigra; Deborah de Almeida Bauer Guimarães; César G Prucca; Otniel Freitas-Silva; Anderson J Teodoro; Germán A Gil
Journal:  Oxid Med Cell Longev       Date:  2021-05-18       Impact factor: 6.543

5.  The Antioxidant Content of Coffee and Its In Vitro Activity as an Effect of Its Production Method and Roasting and Brewing Time.

Authors:  Maciej Górecki; Ewelina Hallmann
Journal:  Antioxidants (Basel)       Date:  2020-04-10

6.  Antioxidant and Anti-Inflammatory Activity of Coffee Brew Evaluated after Simulated Gastrointestinal Digestion.

Authors:  Luigi Castaldo; Marianna Toriello; Raffaele Sessa; Luana Izzo; Sonia Lombardi; Alfonso Narváez; Alberto Ritieni; Michela Grosso
Journal:  Nutrients       Date:  2021-12-05       Impact factor: 5.717

Review 7.  A Decade of Research on Coffee as an Anticarcinogenic Beverage.

Authors:  Ayelén D Nigra; Anderson J Teodoro; Germán A Gil
Journal:  Oxid Med Cell Longev       Date:  2021-09-15       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.